Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Attending the #ERSCongress2024? Join this postgrad course to hear Lennie Derde discuss the landscape of adaptive platform #clinicaltrials in #criticalcare and the REMAP-CAP trial 👇 ERS UMC Utrecht International Infection & Immunity UMC Utrecht European Commission

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

🚩 Major REMAP-CAP milestone: 14.000 patients have been enrolled in the trial globally. A big THANK YOU to the whole #remapcapfamily for the dedication and commitment to improving outcomes for patients with community-acquired #pneumonia 👏🏻👏🏾👏🏼 #10YearsREMAPCAP

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

📢 Debunking Myths and Highlighting Facts: Understanding Clinical Trials for Patients with Cancer We have a new fact sheet on clinical trials that we are pleased to share with patients and providers. 💊 Clinical trials are critical in advancing cancer treatment and providing

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Celebrating 5 years of impact of GBM AGILE #FasterTogether

Over the last five years #GBMAGILE, a first of its kind clinical trial for patients with #glioblastoma, has achieved significant milestones through the collaborative efforts of numerous individuals, ongoing support from partnerships, and a community driven to improve treatment

A heartfelt thank you to our staff for their dedication and teamwork. We are grateful for your hard work, planning, and solution-oriented thinking which drive #GBMAGILE forward each day. Thank you to our staff past and present, collaborators, partners, and vendors for your

September is #OvarianCancerAwarenessMonth GCAR is committed to expediting the advancement of new treatments for individuals with rare and life-threatening conditions including #ovariancancer. Our focus is on establishing platform trials that enhance efficiency, shorten drug